Delta Air Lines CEO Ed Bastian revealed that the new delta variant of Covid-19 hasn’t hurt their sales and that they are even getting 60 to 90 days of bookings in advance.
Bastian noted that the variant hasn’t impacted them and that they are learning to live with the health problem.
Summer travel and future travel bookings remain strong with domestic leisure travel surpassing 2019 levels before the pandemic.
Delta said that 72 percent of their employees and a “vast majority” of their customers are vaccinated.
Other airline CEOs, including those of American Airlines and United Airlines, also said that domestic leisure bookings have largely rebounded to 2019 levels and that business travel is also recovering, albeit at a much slower pace.
The delta variant became the dominant strain in the US earlier this month.


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



